Blogs / News

Investing in the unlisted market can offer unique opportunities for investors looking to diversify their portfolio and potentially earn significant returns.

10 May, 2025,

419 0

PharmEasy Ups Diagnostic Game with 'On-Time or Free' Promise

PharmEasy, one of India's leading digital healthcare platforms, has launched a fresh marketing campaign designed to drive adoption and trust in its diagnostic testing services. At the center of this i...

03 Dec, 2024,

680 3

PharmEasy’s Struggles and Investment Returns: A Look into Prosus’ Portfolio Performance

In the first half of the fiscal year, online pharmacy startup PharmEasy delivered disappointing results for global investment firm Prosus, posting an internal rate of return (IRR) of -38%. This underp...

07 Nov, 2024,

549 3

AIOCD Raises Concerns Over Potential Instamart-PharmEasy Partnership for 10-Minute Medicine Delivery

AIOCD Raises Concerns Over Potential Instamart-PharmEasy Partnership for 10-Minute Medicine Delivery The All India Organisation of Chemists and Druggists (AIOCD) has raised significant alarm over a p...

10 Sep, 2024,

3254 9

Comprehensive Report on PharmEasy's FY24 Financial Performance

Comprehensive Report on PharmEasy's FY24 Financial Performance Introduction PharmEasy, a leading digital healthcare platform in India, has made significant strides in optimizing its operations and f...

26 Jul, 2024,

505 3

Pharmeasy Subsidiary, Thyrocare Expands Northern India Footprint with Polo Labs Acquisition

Thyrocare Technologies has expanded its presence in Northern India by acquiring the pathology business of Polo Labs. The acquisition aims to enhance Thyrocare's diagnostic capabilities in the region,...

30 Apr, 2024,

694 3

PharmEasy raises INR 1804 Cr at 90% lower valuation in Rights Issue

PharmEasy, a leading digital pharmacy, recently secured INR 1,804 Cr ($216.2 Mn) in funding led by the Manipal Group chairman Ranjan Pai's family office, following the Competition Commission of India'...

31 Mar, 2024,

412 2

Ranjan Pai's Investment Clears Regulatory Hurdles, Opens Doors for PharmEasy's Future

The Competition Commission of India (CCI) has given approval for Manipal group chief Ranjan Pai's significant investment in PharmEasy, a rising star in the online pharmacy realm. This development, dis...

06 Feb, 2024,

106 0

Pharmeasy subsidiary, Thyrocare is set to acquire Channai based Think Health Diagnostic

Thyrocare, a diagnostics platform owned by PharmEasy, is set to acquire Think Health Diagnostics, based in Chennai to expand its services. The acquisition, facilitated through a share swap agreement,...

05 Feb, 2024,

158 0

CCI give nod for the acquisition of stakes in PharmEasy

The Competition Commission of India (CCI) has given its nod for the acquisition of stakes in PharmEasy by various entities, notably the Naspers group from South Africa and Singapore's sovereign wealth...